Graves' disease (GD) is an autoimmune disorder characterized by hyperthyroidism and is commonly associated with diffuse thyroid enlargement. The coexistence of thyroid nodules in GD presents diagnostic and management challenges, particularly when malignancy is a concern. We report a 44-year-old woman with asymptomatic biochemical hyperthyroidism detected during routine screening. Initial ultrasound revealed a subcentimeter right thyroid nodule (TI-RADS TR4), for which surveillance was recommended. Follow-up imaging demonstrated interval growth, prompting fine-needle aspiration that was suspicious for papillary thyroid carcinoma (PTC) (Bethesda V). Molecular analysis revealed a rare BRAF mutation with an estimated ~70% probability of malignancy. The patient underwent total thyroidectomy with central neck dissection, confirming a 1.1 cm classic PTC with microscopic nodal metastasis (pT1bN1a). She recovered uneventfully and remains under endocrinology follow-up. This case underscores the importance of structured ultrasound surveillance in patients with GD, even in the absence of clinical symptoms. A multimodal diagnostic approach incorporating imaging, cytology, and molecular analysis can facilitate early detection and informed risk stratification, supporting timely and appropriate management.
Figueredo et al. (Fri,) studied this question.